The million dollar drug that patients can't access
Wednesday, November 14, 2018 - 11:50
in Mathematics & Economics
Glybera is a made-in-Canada discovery that made history, becoming the world's first drug approved to treat a genetic disease. But when it went on the market at a price of $1 million, it was immediately labelled the most expensive drug in the world and was only sold once.